CAPITOL COUNSEL LLC

Lobbying for AMGEN INC. · Human therapeutics company in the biotechnology industry

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 18, 2026

Lobbying activity 1

Medicare/Medicaid

Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues. AI in health care.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.